95110 ⎘
Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms Radicals substituted by nitrogen atoms
IONIZABLE CATIONIC LIPIDS
#2Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents
#3Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents
#4IONIZABLE CATIONIC LIPID COMPOUNDS
#5Novel Ionizable Cationic Lipids
#62,6-DIBENZYLIDENECYCLOHEXANONE OXIME COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
#7Sulfur-Containing Lipids
#8NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#9SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS
#10IONIZABLE LIPIDS
#11IONIZABLE CATIONIC LIPIDS
#12KC2-Type Lipids
#13Method for Producing an Ionizable Lipid
#14Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents
#15Lipids and compositions for the delivery of therapeutics
#16FUNGICIDAL ARYL AMIDINES
#17NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#18Ionizable cationic lipids
#19NOVEL PROCESSES FOR PREPARATION OF TEZACAFTOR
#20Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use Thereof
#21SULFUR AND AMIDE TROPOLONE INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USES THEREFOR
#22Ionizable cationic lipids
#23Water-soluble ynamide coupling reagent and preparation method and use thereof
#24Lipids and compositions for the delivery of therapeutics
#25NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#26Hydrophilic polymer derivative having cyclic benzylidene acetal linker
#27Nitrogen and dioxolane-containing hydrofluoroethers and methods of using the same
#28Compounds and methods for inducing chondrogenesis
#29Antibody-drug conjugate having cyclic benzylidene acetal linker
#30Acid labile surfactants
#31Lipids and compositions for the delivery of therapeutics
#32NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE
#335-azido-5-deoxy-2 :3-isopropylidene-D-arabinose compounds; their method of manufacture and their use for the synthesis of ARA-N3, KDO-N3 and 4EKDO-N3
#34Lipids and lipid compositions for the delivery of active agents
#35COMPOSITIONS FOR NUCLEIC ACID DELIVERY
#36Compound and method for manufacturing organic material
#37Nucleic acid-containing lipid nanoparticles
#38Lipid derivative in which hydrophilic polymer is bound through cyclic benzylidene acetal linker
#39Lipids and lipid compositions for the delivery of active agents
#40Process for preparing aminotetrahydropyrans
#41LSD1 inhibitors and uses thereof
#42Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides
#43Lipids and compositions for the delivery of therapeutics
#44Lipids and compositions for the delivery of therapeutics
#45NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#46Amination and hydroxylation of arylmetal compounds
#47Lipids and compositions for the delivery of therapeutics
#48CATIONIC LIPID
#49Antibody-drug conjugate having cyclic benzylidene acetal linker
#50Poly(ADP-ribose) polymerase 1 inhibitors structurally unrelated to NAD
#51Method for producing 2-amino-substituted benzaldehyde compound
#52Low molecular weight cationic lipids for oligonucleotide delivery
#53DEGRADABLE ISOCYANATE COMPOUNDS AND APPLICATIONS THEREOF
#54Method of generating linkage-specific di-and polyprotein probes
#55Lipids and compositions for the delivery of therapeutics
#56Lipids and compositions for the delivery of therapeutics
#57Lipids and lipid compositions for the delivery of active agents
#58Amino lipids and methods for the delivery of nucleic acids
#59Cyclic acetal, cyclic ketal diamines epoxy curing agents and degradable polymers and composites based thereon
#60Compounds and methods for inducing chondrogenesis
#61Low molecular weight cationic lipids for oligonucleotide delivery
#62Method of preparation of alpha galactosyl ceramides compounds
#63Lipids and compositions for the delivery of therapeutics
#64Method for synthesizing sapropterin dihydrochloride
#65Production method for compound comprising amino group and/or hydroxyl group
#66Method for synthesizing sapropterin dihydrochloride
#67Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#68Compounds for the treatment of proliferative disorders
#69Lipids and lipid compositions for the delivery of active agents
#70Compounds and methods for inducing chondrogenesis
#71Low molecular weight cationic lipids for oligonucleotide delivery
#72Merocyanine derivatives
#73Compounds for organic electroluminescent devices
#74PROCESS FOR PRODUCING ESTER COMPOUND
#75Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
#76Compositions for nucleic acid delivery
#77Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor
#78Thromboxane A2 (TP) receptor antagonists
#79Cyclic cationic lipids and methods of use
#801, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
#81Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#82INTEGRATED MICROFLUIDICS FOR HIGHLY PARALLEL SCREENING OF CHEMICAL REACTIONS
#83Cationic lipids and methods for the delivery of therapeutic agents
#84Small molecule CD4 mimetics and uses thereof
#85NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#86Redox drug derivatives
#87Lipids and compositions for the delivery of therapeutics
#88ORGANIC COMPOUNDS
#89Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
#90Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
#91Lipids and compositions for the delivery of therapeutics
#92Lipids and compositions for the delivery of therapeutics
#93Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#94Amino lipids and methods for the delivery of nucleic acids
#95Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
#961, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
#97Compositions and methods for silencing apolipoprotein B
#98Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#99Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#100Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#101Insecticidal compounds
#102COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS
#103Alkynyl derivatives useful as DPP-1 inhibitors
#104Amine-containing lipids and uses thereof
#105SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#106Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic method thereof
#107Sulfamoyl-phenyl-ureido compounds and their use as medicament
#108Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#109CATIONIC LIPIDS AND USES THEREOF
#110Compounds for the treatment of proliferative disorders
#111N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS
#112Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
#113Process for preparing gabapentin
#114NON-IMIDAZOLE ARYLOXYALKYLAMINES
#115PAI-1 inhibitor
#116Cationic Lipids and Uses Thereof
#117Glycolipid Derivative and Drug Containing the Same as Active Component
#118Indane compounds as CCR5 antagonists
#119Benzoylurea Compounds and Use Thereof
#120Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#121Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#122Organic Compounds
#123MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
#124NON-IMIDAZOLE ARYLOXYALKYLAMINES
#125Bisbenzamidines for the Treatment of Pneumonia
#126Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#127Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#128Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#129Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#130Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#131Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#132Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#133Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#134N-aryl-N'alkyl sulfamides as MEK inhibitors
#135Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
#136Non-imidazole aryloxyalkylamines
#137Derivatization of non-natural amino acids and polypeptides
#138Therapies using non-natural amino acids and polypeptides
#139N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
#140Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#141Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic intermediates, and synthetic method thereof
#142Indane compounds as CCR5 antagonists
#143Nitroaniline-based alkylating agents and their use as prodrugs
#144Substituted benzanilide compound and noxious organism controlling agent
#145Non-imidazole aryloxypiperidines
#146Cereal-based charcoal binder